This information was originally presented on September 20, 2013, at the NCCN 8^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

The 2014 NCCN Clinical Practice Guidelines in Oncology for Chronic Myelogenous Leukemia recommend quantitative reverse-transcription polymerase chain reaction (qRT-PCR) standardized to International Scale (IS) as the preferred method for monitoring molecular response to tyrosine kinase inhibitor

Join Guillermo Garcia-Manero, MD and Elias Jabbour, MD as they present their multidisciplinary expertise on a range of cases pertaining to chronic myelogenous leukemia.

Join Guillermo Garcia-Manero, MD and Elias Jabbour, MD as they present their multidisciplinary expertise on a range of cases pertaining to chronic myelogenous leukemia.

This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

The Westin Diplomat
Hollywood, Florida

This information was originally presented on March 17, 2012, at the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida.